How Are Research Peptides Made? Solid-Phase Synthesis and the Documentation Trail

Published 2026-10-27 · Last updated: 2026-10-27 · By: Index Peptides technical team

Research peptides are made by chemical synthesis, most commonly solid-phase peptide synthesis (SPPS). Amino acids are joined one at a time, in a defined order, onto a growing chain anchored to an insoluble resin; the finished chain is then released, stripped of its protecting groups, purified and freeze-dried. Each stage leaves a mark on the paperwork, which is why a batch is documented with a purity figure against a stated method and an identity check by mass. This page explains the process at a general level and connects it to the documents that follow. It is not a laboratory method, and it says nothing about how any particular supplier's batches were made.

Research use only. Not for human or animal consumption.

What chemical peptide synthesis is

A peptide is a chain of amino acids joined by peptide (amide) bonds, and the order of those amino acids, the sequence, defines the compound. Chemical synthesis builds the chain one amino acid at a time. Each addition, called a coupling, joins the carboxyl group of one amino acid to the amino group of the next.

Two facts shape the whole process. First, the coupling reaction does not happen on its own: the amino acids have to be activated, using coupling reagents that generate more reactive derivatives so the bond can form. Second, amino acids carry more than one reactive group, so an uncontrolled mixture reacts in unwanted combinations. Even a simple mixture of alanine and glycine can give four different dipeptides if nothing directs the reaction. Protecting groups solve this by blocking every reactive site except the one meant to react.

Chemists use two kinds:

• Temporary protecting groups cover the amino end of each incoming amino acid and are removed after each coupling so the next amino acid can attach. The main ones are Fmoc, removed under basic conditions with piperidine, and Boc, removed under acidic conditions with trifluoroacetic acid.
• Permanent protecting groups cover reactive side chains, such as the extra amino group on lysine, and stay in place until the chain is complete.

Chemical synthesis normally runs from the C-terminus towards the N-terminus, the opposite direction to the way cells assemble proteins.

Solid-phase peptide synthesis (SPPS)

In SPPS, the first amino acid is anchored by its C-terminus to an insoluble resin support, and the chain is built outwards from that anchor. Because the growing peptide is attached to a solid, excess reagents and soluble by-products can simply be washed away after each step instead of being separated by a purification each time. The approach was developed by Bruce Merrifield, who received the 1984 Nobel Prize in Chemistry for it.

Each amino acid is added by repeating the same four steps:

1. Deprotect: remove the temporary protecting group from the end of the chain.
2. Wash: rinse away the deprotection reagents.
3. Couple: add the next activated, protected amino acid.
4. Wash: remove excess reagents and soluble by-products.

That repetition is what makes SPPS practical to automate, and it is why SPPS is the standard method for research-scale peptides. The BPC-157 compound page, for example, describes the material as produced by solid-phase peptide synthesis and supplied as a lyophilised powder.

No step is perfectly efficient. When a coupling does not go to completion on every chain, some chains miss an amino acid (deletion sequences) and some stop growing early (truncated sequences). A 15-residue peptide needs fifteen couplings, so small shortfalls at each one add up, and the crude product is a mixture of the target sequence and closely related variants.

Cleavage, deprotection and purification

When the last amino acid is attached, the chain is released from the resin (cleavage) and the permanent side-chain protecting groups are removed, commonly in a single acidic treatment. What remains is crude peptide: the target sequence together with deletion and truncated variants, incompletely deprotected chains and other side products.

The crude material is then purified, most commonly by preparative reversed-phase HPLC, which separates the target peptide from related impurities according to how strongly each one is retained on the column. Fractions containing the target are pooled, and the purified solution is lyophilised (freeze-dried) to a dry solid, the stable form in which research peptides are supplied. The freeze-drying step is explained in what is lyophilisation.

Many purified peptides are isolated as salts, commonly TFA or acetate, because of the acids used during cleavage and purification. That is why a certificate may record a counterion, and why the batch certificate states the form that was actually tested.

From synthesis to documentation

The finished material is filled into sealed vials as a lyophilised powder and assigned a lot number. From that point the documentation takes over:

• Identity reference. The compound is defined by its sequence, and the sequence fixes the molecular formula and expected molecular weight. How those figures are calculated is set out in peptide molecular weight and formula.
• Batch results. Each batch is documented on a certificate of analysis that reports results against named methods, typically HPLC purity and, where that test was run, mass-spectrometry identity. The fields are explained in what is a COA for a research peptide.
• Traceability. The lot number links the vial, the certificate and the order, as described in batch traceability from order to COA.

Why the process explains the paperwork

The synthesis route is the reason certificates look the way they do:

• Purity is reported as area percent against a method. The main impurities are close relatives of the target: deletion and truncated sequences and side products with similar chemistry. HPLC separates them into peaks, and the purity figure is the target peak's share of the detected area under that method. A different method can resolve those relatives differently, so the method line is part of the result.
• Identity has to be measured, not assumed. A deletion sequence missing one amino acid can sit close to the target on a chromatogram yet has a different mass. Mass spectrometry compares the detected mass with the expected molecular weight; a name on a label cannot do that.
• The lot number matters. Every synthesis and purification run is a separate event, so results from one batch say nothing about the next.

To check a specific lot, enter the lot number from the vial at /verify and read the certificate for that exact lot, including which results it reports.

What this page does not cover

It is a general description of a chemical process. It is not a recipe or an apparatus guide, it does not describe how any particular Index Peptides batch was manufactured, and it contains no use information of any kind.

FAQ

How are research peptides made?

Most research peptides are made by solid-phase peptide synthesis. Amino acids are added one at a time to a chain anchored on an insoluble resin, using protecting groups so only the intended bond forms. The finished chain is cleaved from the resin, deprotected, purified and freeze-dried to a powder.

What is solid-phase peptide synthesis?

It is a chemical method in which the growing peptide chain is attached to an insoluble resin support. Each amino acid is added by repeating the same steps: deprotect, wash, couple, wash. Because the chain stays on the solid, excess reagents are washed away, which makes the process practical to automate.

Why are protecting groups needed in peptide synthesis?

Amino acids have more than one reactive group, so unprotected mixtures react in unwanted combinations. Temporary groups such as Fmoc or Boc block the chain end between couplings, and permanent groups block reactive side chains until the chain is finished, so only the intended peptide bond forms at each step.

Why does a synthesised peptide need purity and identity testing?

Couplings are not perfectly efficient, so crude material contains closely related deletion and truncated sequences. HPLC reports how much of the detected material is the target peak under a stated method, and mass spectrometry checks that the detected mass matches the expected molecular weight. One result does not replace the other.

Does this describe how Index Peptides batches are made?

No. This is a general description of solid-phase synthesis. For a specific lot, Index publishes the batch record and certificate, which can be checked by lot number at /verify. Research use only. Not for human or animal consumption.

Research use only. Not for human or animal consumption.